octagam 50 mg/ ml
octapharma (2) - immunglobulin, normalt, humant - infusjonsvæske, oppløsning - 50 mg/ ml
vesicare 1 mg/ ml
astellas pharma - kastrup - solifenacinsuksinat - mikstur, suspensjon - 1 mg/ ml
isturisa
recordati rare diseases - osilodrostat fosfat - cushing syndrome - kortikosteroider for systemisk bruk - isturisa er angitt for behandling av endogent cushings syndrom hos voksne.
lorazepam macure 4 mg/ ml
macure pharma aps - lorazepam - injeksjonsvæske, oppløsning - 4 mg/ ml
mesalazin orion 500 mg
faes farma - mesalazin - enterotablett - 500 mg
abiraterone mylan
mylan ireland limited - abirateronacetat - prostata neoplasmer - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
alluzience 200 e/ ml
ipsen pharma - botulinumtoksin type a - haemagglutininkompleks - injeksjonsvæske, oppløsning - 200 e/ ml
carmustine macure 100 mg
macure pharma aps - karmustin - pulver og væske til konsentrat til infusjonsvæske, oppløsning - 100 mg
natriumklorid noridem 9 mg/ ml
noridem enterprises ltd. - natriumklorid - injeksjonsvæske, oppløsning - 9 mg/ ml
meriofert set 150 ie
ibsa farmaceutici italia s.r.l. - menotropin - pulver og væske til injeksjonsvæske, oppløsning - 150 ie